Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$73,714,575
+$17,609,525 QoQ
Shares Held
61,458
+0.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#449
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DAVIS R M INC holds $148,422,330 across 9 Drug Manufacturers - General names. LLY ranks #1 (49.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
61,458 | $73,714,575 | |
| 2 | JNJ |
Johnson & Johnson
|
249,911 | $63,469,896 | |
| 3 | ABBV |
AbbVie Inc.
|
18,009 | $4,531,784 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,586 | $3,030,801 | |
| 5 | AMGN |
Amgen Inc
|
6,701 | $2,426,566 | |
| 6 | AZN |
Astrazeneca PLC
|
1,871 | $354,779 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,425 | $312,588 | |
| 8 | PFE |
Pfizer Inc
|
12,484 | $300,614 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,714,575 | 61,458 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $56,105,050 | 60,999 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $64,789,239 | 60,287 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $45,300,836 | 59,372 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $42,220,903 | 54,162 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $41,268,244 | 49,967 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $34,225,848 | 44,334 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $32,102,921 | 36,236 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $29,470,119 | 32,550 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $22,620,742 | 29,077 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $13,862,420 | 23,781 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,575,545 | 12,242 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,799,341 | 5,969 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,053,995 | 5,981 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $2,228,331 | 6,091 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,944,626 | 6,014 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,966,130 | 6,064 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,944,452 | 6,790 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,758,140 | 6,365 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,426,733 | 6,175 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,458,140 | 6,353 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,201,813 | 6,433 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,118,565 | 6,625 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $877,462 | 5,928 | Shares | Sole | 2020-12-01 | |
| 2020-06-30 | $973,259 | 5,928 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $822,332 | 5,928 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||